Professor Dr FONG Choong Yi is a medical graduate from University of Nottingham, UK. He trained in Paediatrics and Paediatric Neurology in UK. His UK Paediatric Neurology specialty training include working in tertiary Neurology units at Great Ormond Street Hospital London, Evelina Children’s Hospital London and Bristol Royal Children’s Hospital. He had further subspecialty dual-fellowship training in Paediatric Epilepsy and Paediatric Electroencephalography at Brisbane, Australia (Mater & Royal Children’s Hospital Brisbane) and Melbourne, Australia (Royal Children’s Hospital Melbourne). He also is a fellow of the Royal College of Paediatrics and Child Health, UK. He is currently appointed Professor and Senior Consultant Paediatric Neurologist at University Malaya, Kuala Lumpur, Malaysia. He is head of the Paediatric Neurology division from 2014. He developed and oversees the Comprehensive Paediatric Epilepsy evaluation service in University Malaya.  He has published numerous peer-reviewed ISI publications. His research interests include paediatric epilepsy, paediatric bone health, paediatric neurology and using novel information technology applications in improving the quality of lives of children with neurological disorders. He also specialises in non-invasive and invasive epilepsy surgery assessment including long-term video-EEG monitoring, intracranial monitoring, electrocorticography and cortical stimulation. In recognition of his excellent service, he was awarded the University of Malaya excellent service award in 2016, 2019 and 2023. He was awarded the national Malaysian Society of Neuroscience Best Publication (Clinical) award in 2017 and the University of Malaya Best Clinical Neuroscience Publication award in 2019. Many of his postgraduate research students under his supervision have also won national research prizes. In 2019, he was awarded the Endeavour Executive Leadership Award by the Australian government. Professor Dr Fong plays an active role in advocation, education and forming collaborations in Child Neurology. Nationally, he is a co-author of the 2017 Malaysian Consensus Guidelines on the Management of Epilepsy, committee member of the 2019 & 2024 Malaysian Consensus Statement of Brain Death and the Malaysia National Specialist Register (NSR) Paediatric Neurology Subspecialty credentialling committee member. He is currently Vice President of Malaysian Society of Neurosciences, executive council member of Malaysian Epilepsy Council and the Malaysian Chapter of Child Neurology and Developmental Paediatrics from 2022-2026. He is a life member of the International Child Neurology Association. He was the treasurer of the Malaysian Chapter of Child Neurology & Developmental Paediatrics from 2014-2016. In the Asian region, he is a member of the Asian Epilepsy Academy (ASEPA) International League against Epilepsy and helps in running epilepsy and EEG workshops throughout the Asian region as a faculty member. He trains many overseas Paediatric Neurology fellows from the Asian region. Internationally, he is also an appointed Task Force member of the International League against Epilepsy (ILAE) on Paediatric Psychiatric Issues of the Commission of Psychiatry and on Research Advocacy of Children of the Commision on Paediatrics from 2017-2021 and 2022-2025.

                Dr Moy is a Professor of Epidemiology and Public Health, attached with the Department of Social & Preventive Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.  She teaches Epidemiology, Nutritional Epidemiology, Research Methodology and Evidence-Based Medicine to both undergraduate and postgraduate candidates.   Her research interests include Translational Research in the prevention of non-communicable diseases (NCDs) in the community setting, Workplace Wellness and the effects of obesity and lifestyle behaviours (diet, physical activity etc ) on NCDs.                    Dr Moy is an established researcher and she has been included in the prestigious World’s Top 2 % Scientists in the Stanford University’s list for the last five conservative years (2020 to 2024).  Her expertise in obesity research is ranked top 2.8% among the published authors worldwide on Obesity from 2010 through 2023 (ExpertScape).       Dr Moy has vast experience in running cohort study.  Currently, she heads a cohort study comprising of almost 15,000 teachers from the Peninsular Malaysia (CLUSTer).  A biobank with serum, plasma and buffy coat was set up.  The study aims to determine the temporal relationship between lifestyle practices (diet and physical activity) and stress with cardiovascular diseases with repeated measurements over time.    This cohort study started in 2013 and up to date, a total 14 PhD/DrPH and one MMedSc (Research) candidates worked on this cohort study and ten of them have graduated.  Eighteen ISI articles are published from this cohort.                   Dr Moy is also actively involved in another study that works on the development of a mobile diet app using image capture as the dietary assessment method. This project is in collaboration with co-researchers in the field of Artificial Intelligence and Behavioural Science.  The goal is to have users monitor their diet and for researchers in the nutrition field to have a better tool in dietary assessment. This mobile diet app has registered for patent and copyrights.  Efforts to further refine it for commercialisation is ongoing.                   Dr Moy has generated research grants amounting to more than RM2.5 million. She published more than 100 manuscripts in peer review journals. She is also active in supervising research candidates.  To date, she has successfully supervised to completion more than 50 DrPH, PhD, MMedSc (Research) and MPH candidates.                    Dr Moy initiated and established the University of Malaya Wellness Program in 2008 and coordinated the program until 2013. She also co-ordinated the implementation of Clinical Epidemiology-Evidence Based Medicine module in the MBBS curriculum in 2008.  She was the coordinator for the Master of Public Health (MPH) program from 2018 to 2022.                  She served as Head of the Centre of Epidemiology and Evidence Based Practice (CEBP), one of the top ten research centres in Universiti Malaya, in 2024 - 2025.  She is a certified Cochrane Trainer and actively conducts workshops on Cochrane Systematic Review Protocol Development.    She serves as associate editors for international and local journals. She also reviews manuscripts for both local and international journals.                   She actively engages with the media in health advocacy especially in the prevention of obesity and NCDs, promotion of healthy lifestyle and lately in the preventive measures of COVID-19 as well as promotion of vaccination for COVID-19.                    In summary, Dr Moy has a rich portfolio in teaching, research, mentorship and health advocacy.

Dr. Arutchelvan Rajamanikam is a distinguished researcher in medical parasitology and microbiology, recognized for his contributions to parasite genomics and bacteria–parasite interactions. Currently serving as Senior Lecturer at the Faculty of Medicine, Universiti Malaya, he leads cutting-edge research at the intersection of gut microbiota, protozoan parasites, and host-pathogen dynamics. His work is particularly noted for advancing the understanding of Blastocystis sp. biology, where he has helped redefine its pathogenic potential through integrative genomic, transcriptomic, and microbiome-based approaches. Dr. Arutchelvan’s research excellence lies in uncovering the bidirectional relationship between intestinal parasites and bacterial communities, demonstrating how microbial ecosystems influence parasite virulence, drug resistance, and disease outcomes. He employs advanced methodologies including next-generation sequencing, high-throughput drug screening, and computational microbiome analysis, positioning his work at the forefront of translational infectious disease research. His investigations extend to parasite genomics in helminths and protozoa, as well as vector microbiota, with implications for antimicrobial resistance and precision medicine. With over 17 peer-reviewed publications and an H-index of 9, his research has gained international recognition. He has secured competitive funding exceeding MYR 2.1 million as Principal Investigator and collaborator, including prestigious grants from national and international bodies such as the Ministry of Higher Education and UKRI. His collaborative network spans globally renowned institutions, reinforcing the impact and reach of his research. In recognition of his scientific contributions, Dr. Arutchelvan was awarded the Outstanding Researcher in Parasitology by the Venus International Foundation in 2025. He is also an active member of international scientific initiatives, including the European COST Action on Blastocystis under the One Health framework. Beyond research, he contributes as a journal editor, reviewer, and academic leader, shaping the next generation of scientists in parasitology and microbiome research